$100 Invested In Cognizant Tech Solns 20 Years Ago Would Be Worth This Much Today
Cognizant Tech Solns (NASDAQ:CTSH) has outperformed the market over the past 20 years by 12.29% on an annualized basis producing an average annual return of 19.09%. Currently, Cognizant Tech Solns has a market capitalization of $36.48 billion.
If You Invested $1000 In Cognizant Tech Solns 20 Years Ago, Here’s How Much You Would Have Today
Cognizant Tech Solns (NASDAQ:CTSH) has outperformed the market over the past 20 years by 13.0% on an annualized basis producing an average annual return of 20.18%. Currently, Cognizant Tech Solns has a market capitalization of $38.86 billion.
Google Maps Contract Workers Lock Horns With Management Over Returning To Office Policy
Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google Maps contract workers are amid a standoff with their vendor Cognizant Technology Solutions Corp (NASDAQ:CTSH) on…
Cowen & Co. Maintains Outperform on Cognizant Tech Solns, Lowers Price Target to $95
Cowen & Co. analyst Bryan Bergin maintains Cognizant Tech Solns (NASDAQ:CTSH) with a Outperform and lowers the price target from $98 to $95.
What 4 Analyst Ratings Have To Say About Cognizant Tech Solns
Analysts have provided the following ratings for Cognizant Tech Solns (NASDAQ:CTSH) within the last quarter:
RBC Capital Maintains Outperform on Cognizant Tech Solns, Lowers Price Target to $97
RBC Capital analyst Daniel Perlin maintains Cognizant Tech Solns (NASDAQ:CTSH) with a Outperform and lowers the price target from $98 to $97.
Cognizant Tech Solns Q1 Adj. EPS $1.08 Beats $1.04 Estimate, Sales $4.80B Miss $4.83B Estimate
Cognizant Tech Solns (NASDAQ:CTSH) reported quarterly earnings of $1.08 per share which beat the analyst consensus estimate of $1.04 by 3.85 percent. This is a 11.34 percent increase over earnings of $0.97 per share from
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Cognizant Collaborates With Microsoft To Offer New Virtual Healthcare Solution For Remote Patient Monitoring And Improved Care
Cognizant (NASDAQ:CTSH) today announced it is collaborating with Microsoft to deliver a new digital health solution to enhance remote patient monitoring for improved medical care.
Cognizant's new